---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-26-002787"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2026-05-19T10:03:08+00:00"
generated_at: "2026-05-19T10:10:43.854104+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InMed amends Armistice option exercise price from $16.60 to $0.80 per share

## Summary
- Up to 278,761 common shares subject to options; exercise price reduced to $0.80 from $16.60.
- Options originally issued October 26, 2023; amendment entered May 18, 2026.
- Dramatic price reduction may increase dilution risk for existing shareholders if exercised.
- Press release issued May 19, 2026 confirms amendment; no assurance options will be exercised.

## SEC filing metadata
- accession: 0001062993-26-002787
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2026-05-19T10:03:08+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/0001062993-26-002787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-26-002787
- JSON: https://secwatch.observer/filing/0001062993-26-002787.json
- Plain text: https://secwatch.observer/filing/0001062993-26-002787.txt

## Key facts
- Material Agreements
  InMed Pharmaceuticals Inc. amended Armistice Preferred Investment Option Amending Agreement with Armistice Capital Master Fund Ltd. (effective 2026-05-18).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: Armistice Capital Master Fund Ltd.
  - Effective: 2026-05-18
  source text: On May 18, 2026, the Company entered into a preferred investment option amending agreement (the "Armistice Preferred Investment Option Amending Agreement") with Armistice to amend the Armistice Exercise Price contained in the Armistice Preferred Investment Options from $16.60 to $0.80.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/0001062993-26-002787-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.